Printer Friendly

Browse Schizophrenia topic

Drug therapy subtopic

 

Articles

1-300 out of 393 article(s) nextnext page
Title Author Type Date Words
Vanda Receives Negative European Medicines Opinion Regarding Marketing Authorization for Fanaptumfor Schizophrenia Treatment. Jul 24, 2017 140
Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum(TM) for the Treatment of Schizophrenia. Jul 21, 2017 654
Recordati receives approval from European Commission for Reagila as treatment for schizophrenia. Jul 19, 2017 215
Recordati receives approval from European Commission for Reagila as treatment for schizophrenia. Jul 19, 2017 211
Schizophrenia Pipeline Therapeutics Development, Drug Profiles and Key Players Market Analysis Report Now Available at RnRMarketResearch.com. May 31, 2017 849
Schizophrenia Pipeline Therapeutics Development, Drug Profiles and Key Players Market Analysis Report Now Available at RnRMarketResearch.com. May 31, 2017 853
Braeburn Pharmaceuticals' schizophrenia treatment achieves its primary endpoint. May 8, 2017 193
Braeburn Pharmaceuticals' schizophrenia treatment achieves its primary endpoint. May 8, 2017 189
Braeburn Pharmaceuticals Achieves Primary Endpoint in Pivotal Phase 2/3 Study of BB0817, Risperidone 6-month Implant for Treatment of Schizophrenia. Apr 26, 2017 1167
Indivior's schizophrenia drug could improve patient compliance. Mar 23, 2017 226
Indivior's schizophrenia drug could improve patient compliance. Mar 23, 2017 230
Allergan files sNDA with the US FDA for VRAYLAR treatment for schizophrenia in adults. Mar 9, 2017 273
Allergan files sNDA with the US FDA for VRAYLAR treatment for schizophrenia in adults. Mar 9, 2017 269
What are realistic treatment goals? Lingering symptoms require you to evaluate pharmacotherapy and offer psychosocial interventions. Khan, Ahsan Y.; Kalia, Rachna; Ide, George D.; Ghavami, Mona Report Mar 1, 2017 3265
US FDA Approves Sunovion's Latuda for Adolescent Schizophrenia. Jan 31, 2017 227
New drugs for the treatment of agitation in schizophrenia: a systematic review and meta-analysis of inhaled loxapine and infUsed sodium nitroprusside/Novos farmacos para o tratamento da agitacao na esquizofrenia: revisao sistematica e meta-analise da loxapina inalavel e nitroprussiato de sodio. Tonin, Fernanda Stumpf; Piazza, Thais; Borba, Helena Hiemish Lobo; Wiens, Astrid; Pontarolo, Roberto Ensayo Jan 1, 2017 4256
United States : ACADIA Pharmaceuticals initiates Phase III Trial of pimavanserin for adjunctive treatment in patients with schizophrenia. Nov 5, 2016 206
Intellipharmaceutics wins US FDA tentative approval for generic Seroquel XR for schizophrenia and bipolar disorder. Oct 10, 2016 221
Intellipharmaceutics wins US FDA tentative approval for generic Seroquel XR for schizophrenia and bipolar disorder. Oct 10, 2016 217
Alkermes to evaluate metabolic profile of ALKS 3831 for treatment of schizophrenia. Clinical report Oct 4, 2016 256
Allergan and Richter Provide Update on Cariprazine Program. Aug 5, 2016 2278
Treatment effect of antipsychotics in combination with horticultural therapy on the inpatients with schizophrenia: a randomized, case-controlled study. Zhu, Shunhong; Wan, Hengjing; Lu, Zhide; Wu, Huiping; Zhang, Qun; Qian, Xiaoqiong; Ye, Chenyu Clinical report Aug 1, 2016 5573
A review of 2015 drug approvals. Briggs, Gerald G. Jul 1, 2016 2015
Long-acting injectable aripiprazole lauroxil for schizophrenia: administered IM every 4 to 6 weeks aripiprazole lauroxil is an option for patients who need a longer-acting antipsychotic. Khan, Ahsan Y.; Ovais, Muhammad Report Jul 1, 2016 2083
FDA Grants Fanapt Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia. Jun 15, 2016 279
Vanda passes US FDA approval for Fanapt sNDA for treating Schizophrenia. May 27, 2016 212
Vanda passes US FDA approval for Fanapt sNDA for treating Schizophrenia. May 27, 2016 208
Vanda Announces FDA Approval of the Fanapt Supplemental New Drug Application for Maintenance Treatment of Schizophrenia in Adults. May 26, 2016 1324
Despite its Weak Pipeline, Schizophrenia Market May Benefit from Drugs Used in Similar Indications, Says GBI Research. Apr 12, 2016 685
Despite its Weak Pipeline, Schizophrenia Market May Benefit from Drugs Used in Similar Indications, Says GBI Research. Apr 12, 2016 690
FREQUENCY OF PSYCHOTROPIC DRUGS USE BY PATIENTS WITH SCHIZOPHRENIA IN EIGHT YEARS FOLLOW-UP. Report Mar 31, 2016 2563
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults. Mar 16, 2016 2026
Germany,United States : Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia. Jan 15, 2016 533
Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia. Jan 12, 2016 1652
Impact of pharmacists' intervention in improving adherence among patients with schizophrenia. Rahman, Wan Nur Asyiken Wan Ab; Shafie, Sarah Diyana; Ming, Long Chiau Letter to the editor Jan 1, 2016 1544
European Medicines Agency Accepts Fanaptum (iloperidone) Marketing Authorization Application for the Treatment of Schizophrenia in Adults. Dec 22, 2015 877
United States : New Schizophrenia Treatments May Be Effective for Subgroup of Patients. Dec 9, 2015 322
Psychopharmacological treatment for schizophrenia: less is more. Wang, Chuanyue Dec 1, 2015 1582
United States : FDA approves new injectable drug to treat schizophrenia. Oct 7, 2015 384
Altered protein makes mice smart: genetic tweak points to future treatment for schizophrenia. Sanders, Laura Brief article Sep 19, 2015 285
Allergan and Gedeon Richter announces the US FDA's approval for VRAYLAR capsules for the acute treatment of bipolar I disorder and schizophrenia. Sep 18, 2015 305
Allergan and Gedeon Richter announces the US FDA's approval for VRAYLAR capsules for the acute treatment of bipolar I disorder and schizophrenia. Sep 18, 2015 309
United States : FDA approves new drug to treat schizophrenia and bipolar disorder. Sep 18, 2015 485
Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR(TM) (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults. Sep 17, 2015 2496
Vanda Announces FDA Has Accepted for Review the Fanapt Supplemental New Drug Application for Maintenance Treatment of Schizophrenia in Adults. Sep 15, 2015 849
3-month paliperidone palmitate for preventing relapse in schizophrenia. Kubik, Patrice Report Sep 1, 2015 1300
Developing its KarXT treatment for schizophrenia. Aug 6, 2015 108
Efficacy and safety of treating patients with refractory schizophrenia with antipsychotic medication and adjunctive electroconvulsive therapy: a systematic review and meta-analysis. Wang, Wenzheng; Pu, Chengcheng; Jiang, Jiangling; Cao, Qinyi; Wang, Jijun; Zhao, Min; Li, Chunbo Aug 1, 2015 9110
Rationale and evidence for nonstandard first-line treatments for schizophrenia: consider long-acting injectable antipsychotics; use clozapine as second- or third-line therapy only. Gardner, Kristen N.; Nasrallah, Henry A. Report Jul 1, 2015 5157
INVEGA TRINZA(TM), First and Only Four-Times-A-Year Treatment for Schizophrenia, Now Commercially Available. Jun 25, 2015 3383
Intra-Cellular Therapies concludes enrollment in Phase 3 clinical trial of ITI-007 for the treatment of schizophrenia. Jun 16, 2015 301
Intra-Cellular Therapies concludes enrollment in Phase 3 clinical trial of ITI-007 for the treatment of schizophrenia. Jun 16, 2015 297
Schizophrenia treatment cleared by FDA. Jun 1, 2015 105
Invega Trinza for schizophrenia approved. Rajaraman, Madhu Jun 1, 2015 207
U.S. FDA Approves INVEGA TRINZA(TM), First and Only Four-Times-A-Year Treatment for Schizophrenia. May 19, 2015 3755
New drug trialled for schizophrenia. Apr 17, 2015 195
Study Published in The Journal of Clinical Psychiatry Shows INVEGA SUSTENNA Effective Six Months Longer Than Common Oral Antipsychotics in Treatment of Schizophrenia. Apr 15, 2015 2872
New Post-hoc Analyses Extend Understanding of the Efficacy and Safety of Lurasidone in the Treatment of Schizophrenia. Mar 31, 2015 1988
Obesity is an unavoidable adverse drug reaction to atypical antipsychotics. Verma, Hemlata; Rao, S.S.; Verma, V.K. Clinical report Mar 16, 2015 2788
Efficacy of olanzapine and haloperidol in treatment of Schizophrenia in tertiary care hospital. Lavanya, N.; Naveen, Kumar M. Report Feb 19, 2015 3942
Anorexia nervosa as an adverse effect of medication in a case of chronic schizophrenia. D'souza, Mary C.; Ramnathkar, Deepak Jan 26, 2015 1274
Janssen Research & Development receives Priority Review for new drug application for schizophrenia treatment. Jan 21, 2015 150
Janssen Research & Development receives Priority Review for new drug application for schizophrenia treatment. Jan 21, 2015 146
United States : FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 20, 2015 426
FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 19, 2015 2435
CoMentis and Anvyl Announce the Initiation of Clinical Trials for APN1125 for the Treatment of Schizophrenia. Jan 9, 2015 549
CAMH discovery of novel drug target may lead to better treatment for schizophrenia. Dec 9, 2014 550
Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia. Zhang, Shufen; Lan, Guanghua Report Dec 1, 2014 5110
Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study. Hocaoglu, Cicek; Celik, Fatmagul H.; Kandemir, Gokhan; Guveli, Hulya; Bahceci, Bulent Report Dec 1, 2014 6866
Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate. Nov 19, 2014 2431
Alkermes has submitted a NDA to the FDA for approval of aripiprazole lauroxil, an investigational, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia. Oct 1, 2014 142
Shorts. Klotter, Jule Oct 1, 2014 3237
The effects of prolactin-raising and prolactin-sparing antipsychotics on prolactin levels and bone mineral density in schizophrenic patients/Sizofreni tanili hastalarda prolaktini yukselten ve az etkileyen antipsikotiklerin prolaktin seviyesi ve kemik mineral yogunlugu uzerine etkileri. Bulut, Suheyla Dogan; Bulut, Serdar; Tuzer, Verda; Ak, Mehmet; Ak, Emine; Kisa, Cebrail; Aydemir, Ci Report Sep 1, 2014 3951
Are uric acid levels different from healthy subjects in bipolar affective disorder and schizophrenia?: Relationship between clinical improvement and episode severity in male patients/Urik asit duzeyleri iki uclu bozukluk ve sizofrenide saglikli bireylerden farkli midir?: Erkek cinsiyette klinik iyilesme ve donem siddeti ile iliskisi. Gultekin, Bulent Kadri; Kesebir, Sermin; Gul Kabak, Sevgi; Ergun, Ferzan Fikret; Tatlidil Yaylaci, E Report Sep 1, 2014 2484
Alkermes submits NDA to the US FDA for approval of aripiprazole lauroxil for schizophrenia. Aug 25, 2014 209
Alkermes submits NDA to the US FDA for approval of aripiprazole lauroxil for schizophrenia. Aug 25, 2014 205
'Dimmer Switch' To Help Control Dopamine for Treatment of Schizophrenia. Disease/Disorder overview Aug 14, 2014 316
United States : Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 16, 2014 396
Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 14, 2014 2586
Schizophrenia treatments. Muzyk, Andrew Jul 7, 2014 987
Undiagnosed metabolic syndrome and other adverse effects among clozapine users of Xhosa descent. Faasen, N.; Niehaus, D.J.H.; Koen, L.; Jordaan, E. Report Jul 1, 2014 3789
Cognitive deficits and poor functional outcomes in schizophrenia: clinical and neurobiological progress. Nasrallah, Henry A.; Keefe, Richard S.E.; Javitt, Daniel C. Report Jun 1, 2014 7036
Clozapine: taliking about risks, benefits, and alternatives with patients. Marcovitz, David; Freudenreich, Oliver Report Jun 1, 2014 872
Medication adherence in schizophrenia: a comparison between outpatients and relapse cases. Razali, S.M.; Yusoff, M.Z.A.M. Report Jun 1, 2014 4849
Paliperidone: as a possible cause of pericardial effusion/ Paliperidon: muhtemel bir perikardiyal efuzyon nedeni. Sahpolat, Musa; Kucukdurmaz, Zekeriya; Kavakci, Onder; Kurt, Recep Case study Jun 1, 2014 1251
Psychosis resolves, but menses stop: Ms. S, age 30, says her classmates arelworking against her: Paliperidone relieves her psychotic symptoms, but she misses 2 menstrual cycles while taking the drug. What is your next step? Graham, Nicole Renee; Pirzada, Mustafa; Ginory, Almari; Mayol-Sabatier, Laura; Nguyen, Mathew Case study May 1, 2014 2220
What to do when your patient who takes clozapine enters a smoke-free facility. Smith, Tawny L.; Mican, Lisa M. Case study May 1, 2014 1797
Japan : Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for LatudaA(lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia. Apr 1, 2014 425
Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine. Liu, Jianjun; Sun, Jushui; Shen, Xinghua; Guo, Weigang; Zhi, Shengli; Song, Guangming; Xu, Qiuxia; S Report Apr 1, 2014 3924
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for Latuda (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia. Mar 28, 2014 2090
United States : Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse. Clinical report Mar 21, 2014 422
Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse. Clinical report Mar 20, 2014 2234
FDA Grants Fast Track Designation to Omeros' OMS824 Huntington's Disease Program. Feb 5, 2014 1016
What is the relevance of a 2-week response to an antipsychotic? Webster, Amanda J.; Straley, Craig M. Clinical report Jan 1, 2014 2347
New molecular breakthrough brings schizophrenia treatment closer to reality. Dec 31, 2013 247
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia. Dec 9, 2013 2894
Japan : Otsuka and Lundbeck's once-monthly Abilify MaintenaA (aripiprazole) now approved in Europe for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole. Nov 22, 2013 432
United States : Janssen Pharmaceuticals, Inc. to plead guilty and pay over $1.6 billion to resolve allegations of misbranding and filing false claims for its schizophrenia drug Risperdal. Nov 5, 2013 461
Overcoming medication nonadherence in schizophrenia: strategies that can reduce harm: dosing strategies, direct inquiry, psychoeducation can improve outcomes. Macaluso, Matthew; McKnight, Shean Nov 1, 2013 3471
Five Scientific Posters Supporting the Efficacy and Tolerability of Once-Daily Lurasidone - A New Atypical Antipsychotic Treatment for Adults with Schizophrenia. Oct 14, 2013 1919
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease. Sep 30, 2013 988
Japan : Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena(r) in schizophrenia. Sep 21, 2013 418
Lurasidone: classification and indications. Gilley, Laura; Prabhakar, Deepak Brief article Sep 1, 2013 279
Clozapine initiation in crisis teams. Gonzalez, Carlos; Kodimela, Kalyani; Poynton, Amanda Report Sep 1, 2013 2667
Psychotic Symptoms of Schizophrenia Caused by Faulty Brain Switch. Aug 21, 2013 444
AACC Annual Meeting Breaking Science Includes New Tests to Detect Life-Threatening Prostate Cancer, New Cystic Fibrosis Tests That Can Be Measured at the Point of Care, and New Ways to Determine the Safety of Drugs Used to Treat Schizophrenia and Bipolar Disorder. Jul 18, 2013 1053
University's challenge to improve treatment; Scientists' schizophrenia bid. Jul 2, 2013 408
New treatment for schizophrenia discovered. Jul 2, 2013 217
'Brain-shrinkage and schizophrenia' caused by drugs; WARNING TO TEENAGERS OVER DANGEROUS NEW SUBSTANCES. May 18, 2013 552
Long-acting injectable aripiprazole for adult schizophrenia: depot formulation and once-monthly dosing might improve adherence in patients with schizophrenia. Lincoln, Jana May 1, 2013 2003
Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease. May 1, 2013 824
Schizophrenia drug said to hold promise. Apr 22, 2013 360
Schizophrenia and Its Treatment Reviewed by NeuroPerspective. Mar 19, 2013 518
Metabolic complications of schizophrenia and antipsychotic medications--an updated review. Yogaratnam, J.; Biswas, N.; Vadivel, R.; Jacob, R. Mar 1, 2013 5111
Inhaled loxapine for agitation. Citrome, Leslie Feb 1, 2013 3320
Reviva Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. Jan 14, 2013 837
BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013. Jan 7, 2013 1207
Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia. Jan 3, 2013 1317
Vanda Receives Negative Opinion from CHMP on Fanaptum(TM) for the Treatment of Schizophrenia. Dec 13, 2012 883
Is pharmacological intervention necessary in prodromal schizophrenia? Zhao, Jingping; LV, Hailong; Guo, Xiaofeng Essay Dec 1, 2012 1915
Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder. Clinical report Nov 28, 2012 782
DSPE Regulatory Update: Acceptance of the European Medicines Agency Submission for an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 670
DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 937
DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 950
Conversion Disorders, Schizophrenia, Occupational Therapy, Depression and drug addiction discussed by various speakers. Oct 14, 2012 757
Research and Markets: Key Findings from Treatment Algorithms: Schizophrenia. Oct 5, 2012 290
Treatment outcome of schizophrenia in Chinese patients. Kua, Ee Heok Clinical report Oct 1, 2012 562
United States : FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in INVEGA SUSTENNA Updated Product Label. Sep 28, 2012 363
BioLineRx Announces Publication of EAGLE Study Results Demonstrating BL-1020's Efficacy in Improving Cognitive Function in Schizophrenia Patients. Clinical report Sep 27, 2012 1204
Psychology. Author abstract Sep 22, 2012 2658
Antipsychotic drug therapy: proceed with caution. Casey, Georgina Sep 1, 2012 4584
Eli Lilly announces halt to Phase III development of Pomaglumetad Methionil for schizophrenia treatment. Clinical report Aug 30, 2012 235
Eli Lilly announces halt to Phase III development of Pomaglumetad Methionil for schizophrenia treatment. Clinical report Aug 30, 2012 231
Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results. Clinical report Aug 29, 2012 599
New drug target for schizophrenia identified. Aug 14, 2012 461
When and how to use long-acting injectable antipsychotics. Kennedy, William Klugh Report Aug 1, 2012 2132
Meta-analysis of studies in China about changes in P300 latency and amplitude that occur in patients with schizophrenia during treatment with antipsychotic medication. Su, Liang; Cai, Yiyun; Shi, Shenxun; Wang, Liwei Report Aug 1, 2012 4067
Antipsychotics need to pile up: new insights explain delayed action in schizophrenia drugs. Sanders, Laura Jul 14, 2012 445
Intranasal oxytocin aids schizophrenia patients: treatment improves emotion recognition, social functioning, neurocognition in several studies. Worcester, Sharon Clinical report Jul 1, 2012 719
Beyond the brain: in the 1990s, scientists declared that schizophrenia and other psychiatric illnesses were pure brain disorders that would eventually yield to drugs. now they are recognizing that social factors are among the causes, and must be part of the cure. Luhrmann, Tanya Marie Jun 22, 2012 4025
Research and Markets: Pharmacological and Psychosocial Treatments in Schizophrenia. Jun 20, 2012 429
Depot antipsychotics boost compliance. Zoler, Mitchel L. Jun 1, 2012 980
A placebo-controlled trial of bupropion for improving the positive and negative symptoms of schizophrenia. Rezaee, Omid; Masafi M, Saeede; Mohamadrez; Farshad, Akbarpour Report Jun 1, 2012 2741
Zogenix Inc submits IND to FDA for second DosePro candidate Relday for antipsychotic market. May 31, 2012 172
Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients. May 9, 2012 506
Latuda[R] (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia. May 5, 2012 2437
Mylan Inc unveils FDA approved schizophrenia & manic tablets, Zyprexa. Apr 25, 2012 186
TMS guided by fMRI not effective for hallucinations. Boschert, Sherry Clinical report Apr 1, 2012 464
Mylan Inc unveils generic antipsychotic medication Seroquel Tablets 25mg. Mar 29, 2012 157
Mylan Launches Generic Version of Seroquel[R] Tablets, 25 mg. Mar 28, 2012 413
Reviva Pharmaceuticals Announces Enrollment of Patients in Phase 2 Clinical Study of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. Clinical report Mar 12, 2012 933
Cheap acne antibiotic could help ease schizophrenia symptoms. Mar 3, 2012 392
Serum prolactin levels and the acute-phase efficacy in drug-naive schizophrenia treated with ziprasidone and olanzapine (translated version). Wu, X.L.; Wang, J.H.; Hu, S.H.; Tao, J. Report Mar 1, 2012 3182
Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia. Feb 28, 2012 1435
'Chemical cosh' drug doubles death risk in dementia patients. Feb 24, 2012 342
How antipsychotic medications lead to obesity and diabetes. Feb 2, 2012 546
FDA panel recommends loxapine for approval: from a meeting of the FDA's Psychopharmacologic Drugs Advisory Committee. Mechcatie, Elizabeth Jan 1, 2012 1047
Best practices in: the treatment of adults with schizophrenia: managing schizophrenia and overall health. Mattingly, Gregory W. Jan 1, 2012 1793
Off-label use of antipsychotic drugs: significant benefits and some risks found: these drugs should be taken only under the supervision of an experienced psychiatrist or pharmacologist. Jan 1, 2012 472
Alkermes Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia. Dec 19, 2011 1161
New Drug Application for Otsuka's Once-Monthly Aripiprazole Depot Formulation for Maintenance Treatment of Adult Patients with Schizophrenia Accepted for Review by the U.S. Food and Drug Administration. Nov 22, 2011 990
-Lundbeck's Japanese partner applies for US approval of schizophrenia drug. Nov 22, 2011 152
-Lundbeck's Japanese partner applies for US approval of schizophrenia drug. Nov 22, 2011 153
New-onset psychosis: check caffeine use. Whiting, William L. Report Nov 1, 2011 575
Alexza Pharmaceuticals submits European MAA for Adasuve for schizophrenia or bipolar disorder treatment. Oct 28, 2011 134
This month's instant poll. Brief article Oct 1, 2011 101
Research and Markets: Global Schizophrenia Drug Pipeline Capsule - 2011. Sep 29, 2011 402
Monday, 26 September 2011 THEPROFESSIONALS; Ensuring that patients get right prescription for anti-psychotic drugs Dr Jane Harrison explains how the latest phase of 1,000 Lives Plus work on the appropriate use of anti-psychotic drugs will benefit patients. Sep 26, 2011 615
Reserpine for schizophrenia. Report Sep 1, 2011 333
Groups back forcing meds. Correa, Frances Brief article Sep 1, 2011 158
When Compared to Other Atypical Antipsychotics, Fewer Schizophrenia Patients Who Take Zyprexa in the First Line Progress to a Second-Line Therapy within a Year. Jul 27, 2011 511
Cancer drugs may help treat schizophrenia. Jul 21, 2011 244
Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia. Jun 30, 2011 948
Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia. Garg, Rohit; Chavan, B.S.; Arun, Priti Report Jun 1, 2011 2292
Schizophrenia: what can we do about it? Gitrome, Leslie Report Jun 1, 2011 3728
Psychosocial treatments backed for schizophrenia. Jancin, Bruce May 1, 2011 883
INTELLIPHARMACEUTICS FILES ANDA FOR GENERIC SEROQUEL XR. Apr 27, 2011 307
INVEGA Approved as Treatment for Schizophrenia in Adolescents. Apr 11, 2011 2320
Janssen EMEA reports study data for antipsychotic Risperdal Consta. Clinical report Mar 29, 2011 373
Risperdal(R) Consta(R) Associated With Lower Risk of Hospitalisation Compared to Treatment With Other Antipsychotics in Patients With Schizophrenia. Clinical report Mar 25, 2011 1584
New study could lead to potential drug targets for schizophrenia, Parkinson's. Mar 13, 2011 429
European Commission Approves XEPLION(R) for Treatment of Schizophrenia. Mar 9, 2011 1917
EC OKs XEPLION for treatment of schizophrenia. Mar 9, 2011 223
Cognition unaffected by single schizophrenia Tx. Tucker, Miriam E. Mar 1, 2011 929
The intersexual differences of sexual functions and prolactine levels in schizophrenia patients under antipsychotic medication/Antipsikotik tedavi uygulanan sizofreni hastalarinda prolaktin duzeyleri ve cinsel islevlerin cinsiyetlere gore karsilastirilmasi. Dogu, Basri; Kocabiyik, Ahmet; Karson, Fahri; Citak, Serhat; Incesu, Cem Report Mar 1, 2011 2929
Antipsychotics for schizophrenia linked to subtle loss in brain volume. Feb 8, 2011 294
Once-Daily Latuda[R] (lurasidone HCl) Now Available in Pharmacies Nationwide for the Treatment of Patients with Schizophrenia. Feb 3, 2011 2224
Lurasidone for schizophrenia. Lincoln, Jana; Tripathi, Aveekshit Drug overview Jan 1, 2011 1669
Latuda[R] (lurasidone HCl) Significantly Improves Symptoms of Schizophrenia in Fifth Positive Placebo-Controlled Study. Dec 8, 2010 2967
Phase II Study with First-in-Class Investigational Drug Demonstrates Improvement in Negative Symptoms in Patients with Schizophrenia. Dec 6, 2010 1338
Pimozide augmentation therapy in treatment-resistant schizophrenia patients with poor or partial response to clozapine: a retrospective study/Klozapin tedavisine yeterli yanit alinamayan tedaviye direncli sizofreni hastalarinda pimozidle guclendirme yaklasimi: geriye donuk bir degerlendirme calismasi. Kisa, Cebrail; Akdag, Hatice Alkan; Aydemir, Cigdem; Goka, Erol Report Dec 1, 2010 3825
FDA Approves Latuda to Treat Schizophrenia in Adults. Oct 28, 2010 503
FDA Approves Once-Daily LATUDA[R] (lurasidone HCL) for the Treatment of Patients with Schizophrenia. Oct 28, 2010 2200
Over the Next Three Years, Abilify and Seroquel XR Will Be the Fastest-Growing Drugs by Prescriptions for the Treatment of Major Depression. Oct 21, 2010 741
Dopamine model could aid treatment of schizophrenia, drug addiction. Oct 21, 2010 278
Otsuka Announces Phase 3 Aripiprazole Intramuscular (IM) Depot Trial Interim Analysis Reveals Efficacy Criteria Met. Oct 5, 2010 1884
Study finds frequent switching of antipsychotics. Helwick, Caroline Oct 1, 2010 557
New brain research could lead to schizophrenia treatment. Oct 1, 2010 225
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder. Sep 28, 2010 970
Drugs to treat nausea, vomiting 'up clots risk'. Sep 22, 2010 402
FDA OKs expanded indications for Merck's SAPHRIS sublingual tablets. Sep 7, 2010 166
Should you order genetic testing to identify how patients metabolize antipsychotics? Bishop, Jeffrey R.; Chae, Sharon Sep 1, 2010 2040
The quest for the correct dose: recent efforts shed light on antipsychotic dosing, but find much work is left to be done. Glazer, William M. Sep 1, 2010 1279
After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019. Aug 5, 2010 700
Committee for Medicinal Products for Human Use (CHMP) Issues Opinion on European Regulatory Filing for Merck's Atypical Antipsychotic Medication SYCREST[R] (asenapine). Jun 25, 2010 12118
Schizophrenia drug 'shrinks brain'. Jun 8, 2010 269
A study of contingent negative variation and post-imperative negative variation: search for state and trait electrophysiological markers in schizophrenia. Simlai, J.; Nizamie, S.H.; Khess, C.R.J. Clinical report Jun 1, 2010 4038
Schizophrenia drugs turn up volume of brain's key signaling system. May 15, 2010 257
New Study Finds Off-Label Use of Atypical Antipsychotics Increases Risk of Diabetes Among the Elderly. May 13, 2010 998
Early disruption of schizophrenia gene causes problems later. Sanders, Laura Brief article Mar 13, 2010 265
Antipsychotic polypharmacy in schizophrenic inpatients/Yatan sizofreni hastalarinda coklu antipsikotik kullanimi. Ozalmete, Ozlem Albayrak; Ceylan, Mehmet Emin; Ozalmete, Onur; Sevim, Meltem Efe Report Mar 1, 2010 4176
Augmentation of clozapine with pimozide: a case of a treatment-resistant schizophrenic patient/Klozapin tedavisini pimozid ile guclendirme yaklasimi: tedaviye direncli bir sizofreni olgusu. Akdag, Hatice Alkan; Kisa, Cebrail; Bekki, Gulcan; Goka, Erol Report Mar 1, 2010 2689
Paliperidone palmitate: once-monthly treatment option for schizophrenia. Sedky, Karim; Nazir, Racha; Lindenmayer, Jean-Pierre; Lippmann, Steven Drug overview Mar 1, 2010 1145
Emerging Oral Atypical Antipsychotics Will Garner Only Limited Uptake in the Schizophrenia Drug Market. Feb 23, 2010 643
Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders. Feb 4, 2010 917
Dainippon Sumitomo submits NDA for lurasidone for treatment of schizophrenia. Clinical report Jan 5, 2010 173
Metabolic issues can persist even with antipsychotic switch. Boschert, Sherry Report Jan 1, 2010 610
New biosensors show how drugs used to treat schizophrenia work. Dec 14, 2009 276
AstraZeneca's Seroquel XR approved for new indication in USA. Dec 4, 2009 235
Asenapine for schizophrenia and bipolar I disorder. Lincoln, Jana; Preskorn, Sheldon Dec 1, 2009 2383
Aripiprazole approved for autism-related irritability. Mechcatie, Elizabeth Dec 1, 2009 454
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia. Oct 28, 2009 1490
Epilepsy drug could raise schizophrenia risk. Oct 22, 2009 242
The outcome of behavioral intervention with a person living with schizophrenia who exhibited medication noncompliance: a case study. Kanahara, Shunsuke Case study Sep 22, 2009 3962
Iloperidone for schizophrenia: new treatment option for patients who have not fully responded to or cannot tolerate other antipsychotics. Weiden, Peter J.; Bishop, Jeffrey R. Drug overview Sep 1, 2009 2820
Injectable beats oral antipsychotics for bipolar. McNamara, Damian Clinical report Sep 1, 2009 593
Sublingual antipsychotic gets nod from FDA panel: asenapine safe, effective. Mechcatie, Elizabeth Aug 1, 2009 661
Choosing antipsychotics for children with schizophrenia: evidence plus experience: seeking efficacy while managing adverse effects in early-onset psychosis. Report Jul 1, 2009 3339
Panel majority backs olanzapine for teen use. Mechcatie, Elizabeth Jul 1, 2009 541
Schizophrenia drug may help fight cancer. Jun 3, 2009 175
Afraid to leave home. Klein, Carolina A.; Myers, Michael F. Case study Jun 1, 2009 2490
'Singing brains' offer hope for better epilepsy, schizophrenia treatments. May 20, 2009 380
Titan Announces FDA Approval of Fanapt[TM] (Iloperidone) For the Treatment of Schizophrenia. May 7, 2009 359
ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs. Mar 25, 2009 1033
Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia/Sizofrenide metabolik sendrom sikligi, metabolik sendromun ozellikleri ve kullanilan antipsikotiklerle iliskisi. Kaya, Mehmet Cemal; Virit, Osman; Altindag, Abdurrahman; Selek, Salih; Bulbul, Feridun; Bulut, Mahmu Clinical report Mar 1, 2009 4488
Drugs raise death rate for dementia patients. Clinical report Jan 9, 2009 444
WORLD TODAY: Alzheimer's drugs risk. Jan 9, 2009 98
When clozapine is not enough: Augment with lamotrigine? Gray, John A.; Risch, Samuel C. Clinical report Jan 1, 2009 3073
Antipsychotics raise need for health checks. Sullivan, Michele G. Clinical report Nov 1, 2008 312
FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment. Oct 9, 2008 1608
Off-label Medicine Combinations are Predominant Treatment of Schizophrenics According to PLoS Article. Sep 23, 2008 372
Ginkgo biloba and treatment resistant schizophrenia. Finney-Brown, Tessa Sep 22, 2008 488
Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia. Sep 15, 2008 113
LILLY (ELI) & COMPANY - Olanzapine Maintains Treatment Benefit in Schizophrenia. Sep 2, 2008 2354
Among women with schizophrenia who are being treated with antipsychotic medications, an estrogen patch can markedly improve their symptoms, results of a clinical trial show. Brief article Aug 11, 2008 285
Antipsychotic combinations blind step or logical? Though unsupported by evidence, using >1 antipsychotic may make sense for some treatment-resistant patients. Gibson, Aaron P.; Patel, Nick C.; Lauriello, John Disease/Disorder overview Jul 1, 2008 2859
BioLineRx Initiates Phase 2b Clinical Trials of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Jun 12, 2008 1109
FDA adds new indications for aripiprazole. Osborne, Randall Jun 1, 2008 187
New atypical shows efficacy for inpatients in early trial. Henderson, Gina L. Jun 1, 2008 413
ABILIFY(R) (aripiprazole) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia. May 8, 2008 2196
MedImpact Study Highlights the Effects of Restricted Access on Use of Antipsychotic Drugs. Report Apr 29, 2008 496
ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia. Apr 22, 2008 1063
Antipsychotic drugs are doing harm. Mar 16, 2008 788
Do cholinesterase inhibitors enhance cognition in schizophrenia? Disorder's heterogeneity may help explain why the answer is unclear. Risch, Samuel C. Mar 1, 2008 2395
Getting the NAC of a novel schizophrenia Tx. Jancin, Bruce Mar 1, 2008 725
BioLineRx Announces Positive Results From Phase 2a Trial of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Feb 4, 2008 1299
ABILIFY approved for adolescent patients with schizophrenia. Dec 1, 2007 145
OREXIGEN(TM) Therapeutics to Present Data Supporting Novel, PreClinical Drug Combination for Schizophrenia. Nov 1, 2007 242
This month's instant poll. Brief article Nov 1, 2007 191
Innovative polypharmacy: when dopamine blockade is not enough; 'Futuristic' adjuncts to antipsychotics could better address persistent positive and negative symptoms and impaired cognition. Nasrallah, Henry A. Nov 1, 2007 831
Elan Announces the Johnson & Johnson Pharmaceutical Research & Development Submission of a New Drug Application to the FDA for Paliperidone Palmitate Using Elan's Proprietary NanoCrystal(R) Technology. Oct 29, 2007 720
New Survey Conveys Fundamental Shift in the Perceptions of Treatment Outcomes in Schizophrenia. Oct 9, 2007 1028
Risperdal indication extends to teens, kids. Wachter, Kerri Sep 15, 2007 581
Risperdal approved in teens for schizophrenia and BPD. Wachter, Kerri Sep 15, 2007 583
Wyeth drops after court ruling on protonix. Brief article Sep 10, 2007 220
Indications for risperidone expanded to teens, kids. Wachter, Kerri Sep 1, 2007 583
AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia. Aug 29, 2007 617
CATIE results show overlap of schizophrenia, metabolic disorder. Kirn, Timothy F. Aug 1, 2007 435
BioLineRx Initiates Phase II Trial of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Jul 25, 2007 737
IM aripiprazole for acute agitation. Josiassen, Richard C.; Shaughnessy, Rita A. Clinical report Jul 1, 2007 2071
BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. May 16, 2007 643
Antidepressants may benefit prepsychotic teens. Splete, Heidi May 1, 2007 330
The depot paradox: long-acting formulations of antipsychotics can boost treatment adherence rates, but clinicians have been hesitant to use them. Glazer, William M. May 1, 2007 2199
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia. Apr 27, 2007 688
The importance of early treatment of schizophrenia. Apr 1, 2007 2508
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research. Mar 29, 2007 1089
Weitz & Luxenberg Responds to Study on Off-Label Use of Antipsychotics. Feb 6, 2007 488
elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia. Feb 5, 2007 552
Line of research could advance schizophrenia Tx. Goldman, Erik L. Feb 1, 2007 996
Off-label use of atypicals. Schneider, Mary Ellen Brief article Feb 1, 2007 163
Lilly reaches Zyprexa settlement. Schneider, Mary Ellen Brief article Feb 1, 2007 169
FDA approves new drug for schizophrenia. Feb 1, 2007 141
Omeros Receives up to $9 Million toward Development of Schizophrenia Treatment. Jan 10, 2007 470
Johnson & Johnson (New Brunswick NJ) won approval for its once-a-day pill called Invega for treating schizophrenia. Brief article Jan 8, 2007 120
FDA approves extended-release drug for schizophrenia. Walsh, Nancy Jan 1, 2007 386
Schizophrenia, substance use need integrated Tx: take into account the possible synergistic effects between antipsychotics and drugs of abuse. Sherman, Carl Jan 1, 2007 1125
Pfizer is making 20% cut in domestic sales team. Dec 18, 2006 468
Research and Markets: Market Research available on CNS Drug Discoveries 2006: Schizophrenia. Dec 15, 2006 559
Improved monitoring of lipids, glucose needed. Walsh, Nancy Dec 1, 2006 431
First agent for autism treats aggression, tantrums. McNamara, Damian Brief article Nov 15, 2006 264
CUtLASS findings interesting but inconclusive. Sullivan, Michele G. Clinical report Nov 1, 2006 758
HEALTH: Why the term schizophrenia only benefits the drug industry. Oct 10, 2006 178
Data on clozapine augmentation are scarce but do exist. Finn, Robert Aug 1, 2006 777
CATIE support of atypical antipsychotics debated. Kirn, Timothy F. Drug overview Jul 1, 2006 1209
BioLineRx to Present BL-1020, First in Class Small Molecule for the Treatment of Schizophrenia, at the American Psychiatric Association Annual Meeting. May 18, 2006 436
The Market for Typical or Atypical Antipsychotics for the Treatment of Schizophrenia Exceeded $5 Billion in 2005. May 18, 2006 515
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia. May 5, 2006 458
Clinical trials come in for scrutiny. Brief article May 1, 2006 243
Clozapine 'wins again' in phase II of CATIE. McNamara, Damian May 1, 2006 644
BioLineRx Initiates Phase 1 Clinical Trials of BL-1020, First in Class Small Molecule for the Treatment Of Schizophrenia. Apr 10, 2006 515

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters